Filing Details
- Accession Number:
- 0000950117-11-000370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-14 17:19:38
- Reporting Period:
- 2011-04-12
- Filing Date:
- 2011-04-14
- Accepted Time:
- 2011-04-14 17:19:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1420720 | Ibio Inc. | IBIO | Pharmaceutical Preparations (2834) | 262797813 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1053310 | Gerald E Kay | Integrated Biopharma, Inc. 225 Long Avenue, Bldg. 15 Hillside NJ 07205 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-04-12 | 250,000 | $0.50 | 6,136,595 | No | 4 | S | Indirect | FN |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | FN |
Footnotes
- Shares sold in a private transaction pursuant to a Stock Option Agreement originally entered into on May 21, 2010 with Kobus Investments, LLC and Biomed Investments, LLC, as described in detail in the Issuer's Registration Statement on Form S-3 filed with the SEC on March 14, 2011.
- Includes (i) 819,629 shares of common stock held by EGK LLC, of which the reporting person is the manager and (ii) 1,266,706 shares of common stock owned by Integrated BioPharma, Inc. of which the reporting person is a member of a control group. Shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Kay Sheppard with respect to 169,358 shares of common stock.
Billionaire Hedge Funds
